Found 428 matching trials
Selinexor and Ibrutinib in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Aggressive Non-Hodgkin Lymphoma PHASE1 This phase I trial studies the side effects and best dose of selinexor when...
Show More Location
Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center
Learn More & Join Trial
Ibrutinib Adapted to Response in Patients With CLL N/A As everyone knows in clinical practice, Ibrutinib dose reduction in patient...
Show More Location
Multiple Locations
Learn More & Join Trial
Study Evaluating Safety and Efficacy of JCAR017 in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL) PHASE1 This is a Phase 1/2, open-label, multicenter study to determine the efficac...
Show More Status
Active Not Recruiting
Location
Local Institution - 0006
Learn More & Join Trial
Observational Study of Cardiac Arrhythmias During Treatment With BTK Inhibitors or Venetoclax N/A Background:
Bruton s tyrosine kinase inhibitors (BTKi) are used to treat a...
Show More Location
National Institutes of Health Clinical Center
Learn More & Join Trial
TLR9 Agonist SD-101, Ibrutinib, and Radiation Therapy in Treating Patients With Relapsed or Refractory Grade 1-3A Follicular Lymphoma PHASE1 This phase Ib/II trial studies the side effects and best dose of toll-like ...
Show More Location
Stanford University, School of Medicine
Learn More & Join Trial
Combination of Ibrutinib and As2O3 in the Treatment of CLL PHASE3 The purpose of this study is to determine whether the combination of As2O3 ...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study to Evaluate Adverse Events and Change in Disease Activity of Subcutaneous (SC) Epcoritamab in Combination With Oral and Intravenous Anti-Neoplastic Agents in Adult Participants With Non-Hodgkin Lymphoma PHASE2 B-cell Lymphoma is an aggressive and rare cancer of a type of immune cell (...
Show More Status
Active Not Recruiting
Location
The University of Arizona Cancer Center - North Campus /ID# 242219
Learn More & Join Trial
Ibrutinib and Venetoclax in Treating Patients With Chronic Lymphocytic Leukemia After Ibrutinib Resistance PHASE2 This phase II trial studies how well the combination of ibrutinib and venet...
Show More Location
Multiple Locations
Learn More & Join Trial
Ibrutinib in Patients With Refractory/Relapsed Non-GCB Diffuse Large B-cell Lymphoma Non-candidates to ASCT PHASE2 Multicentric phase II trial to evaluate efficacy and safety of ibrutinib in...
Show More Location
Hospital Universitario Son Espases
Learn More & Join Trial
A Study to Evaluate the Bruton's Tyrosine Kinase (Btk) Inhibitor PCI-32765 in Patients With Recurrent Mature B-Cell Neoplasms PHASE1 The purpose of this study is to evaluate the safety and tolerability of Bru...
Show More Location
Multiple Locations
Learn More & Join Trial